 The study is divided into two sequential phases. The Phase I trial is a Phase Screening Eligibility, which includes a screening visit, followed by 2 Visits Eligibility 3 visits. The Phase II study is the treatment phase randomized, double-masked that includes visits during therapy at Week 2, Week 6 and Month 3 